A Multicenter, Open Label Long-Term Safety Study of BHV-3000 in the Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV-3000 in the Acute Treatment of Migraine
The purpose of this study is to evaluate safety and tolerability of BHV-3000 (rimegepant).
Key Inclusion Criteria:
Key Exclusion Criteria: